Thursday, July 24, 2008

AstraZeneca Sues Mylan Over Entocort ANDA

AstraZeneca LP has sued Mylan Pharmaceuticals Inc. in an effort to prevent it from selling a generic version of Entocort EC (budenoside), a drug used to treat Crohn's disease.

The details can be read here.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)